NCT03193541 A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer Status RECRUITING Phase N/A
NCT03193528 A Novel Multiplex ELISA Assay for Evaluating Patients With Gross Hematuria for Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03193515 A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer Status RECRUITING Phase N/A
NCT03174912 In the Prediction of Recurrence and Progression of NMIBC; EORTC or CUETO or Both? Status COMPLETED Phase PHASE4
NCT03171025 Adjuvant Nivolumab Following Chemo-Radiation in Localized Muscle-Invasive Bladder Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03156244 Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients Status COMPLETED Phase N/A
NCT03150836 Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer Status WITHDRAWN Phase PHASE2
NCT03148158 Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident Status UNKNOWN Phase N/A
NCT03147599 Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders Status COMPLETED Phase PHASE4
NCT03147586 Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy Status UNKNOWN Phase PHASE4
NCT03138967 Investigation of Sugammadex in Outpatient Urological Procedures Status COMPLETED Phase PHASE4
NCT03138837 Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage Status UNKNOWN Phase N/A
NCT03134027 Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers Status TERMINATED Phase N/A
NCT03125460 Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer Status COMPLETED Phase N/A
NCT03125200 Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression Status TERMINATED Phase PHASE1
NCT03121768 A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) Status UNKNOWN Phase N/A
NCT03108196 Comparison of Safety and Efficacy of Detaenial Sigmoid Neobladder and Ileal Neobladder Status RECRUITING Phase NA
NCT03106610 Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy Status TERMINATED Phase PHASE1